List view / Grid view
Much rests on the further development of bioanalytical technologies which allow the highest level of sensitivity on small samples, and robust, high reproducibility across large populations. Johan Devenyns, CEO PharmaFluidics, explains further...
Designing appropriate non-clinical safety studies requires thoughtful, and sometimes experimental, consideration of the delivery methodology for the therapeutic. The choice of formulation affects drug release and absorption and has a direct impact on the pharmacokinetic profile and associated response of the model system. The formulation should be compatible with the…
A team of researchers set out to discover the disease pathways of a rare genetic kidney disease and consequently found a compound that stops the disease in its tracks.
Technical leadership in contract development and manufacturing...
Boehringer Ingelheim has announced the launch of a new platform offering free and open access to selected pre-clinical molecules for a non-clinical investigation to scientists worldwide...
Quotient Clinical, the drug development services organisation, announces its renaming to Quotient Sciences (Quotient), following the acquisitions of Co-Formulate, QS Pharma and SeaView Research...
The European Pharmacopoeia chapter on methods for microbiological quality control was recently revised to include a number of significant changes. In this In-Depth Focus Michael Miller provides the first part of this two-part review and Kevin Williams discusses a paradigm change in biologics microbiological contaminant control.
Researchers have found that polymer and hybrid silica-coated microcapsules are efficient in genome-editing...
TK216-vincristine combination appears to halt the ability of Ewing sarcoma to grow and progress...
A genetic fault has been identified in people with an aggressive type of leukaemia that can significantly affect how they respond to treatment...
Researchers find novel combination disrupts multiple factors in aggressive breast cancer...
The FDA has released a draft guidance in response to an increase in the number of post-approval manufacturing supplements...
Russian biotech company BIOCAD plans to leverage competitive advantages to take 5% of the European medicines market
Lonza’s commitment to constant innovation and adding value to its customers and partners is today demonstrated by the launch of Ibex™ Solutions – a unique addition to its current offering...
